Skip to main content
KPTI logo

KPTI · Karyopharm Therapeutics Inc. · Executive Compensation

Track KPTI — free
$0.02 +0.00 (+3.45%) At close · Nov 11 Play latest call Q2 2026 earnings call transcript
Market Cap
$408,266
Shares
22.68M
Volume · Nov 11 8.28M Avg daily vol (3M) 8.53M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Richard Paulson $2,320,902
Reshma Rangwala $2,016,134
Stuart Poulton $1,399,580
Fiscal 2024
Executive Total
Richard Paulson $2,069,341
Reshma Rangwala $1,124,444
Sohanya Cheng $1,094,829
Stuart Poulton —
Fiscal 2023
Executive Total
Richard Paulson $2,626,288
Reshma Rangwala $1,227,789
Sohanya Cheng $1,193,414
Michael Mason $1,139,312
Stuart Poulton $1,109,115
Fiscal 2022
Executive Total
Richard Paulson $6,910,015
Sharon Shacham $6,037,789
Michael Mason $2,699,032
Sohanya Cheng $2,612,718
Ran Frenkel $2,160,250
Michael Mano $2,060,407
Stuart Poulton $1,795,247
Fiscal 2021
Executive Total
Richard Paulson $8,355,172
Sharon Shacham $3,106,591
Michael Kauffman $3,069,589
Michael Mason $1,744,578
Jatin Shah $1,588,213
Ran Frenkel $1,577,203
Fiscal 2020
Executive Total
Senior Clinical $3,937,039
Michael Kauffman $3,937,039
Sharon Shacham $3,670,884
Michael Mason $2,266,816
Fiscal 2019
Executive Total
Senior Clinical $3,231,504
Michael Kauffman $3,231,504
Sharon Shacham $3,020,459
Christopher Primiano $1,623,347
Michael Mason $956,697
Fiscal 2018
Executive Total
Michael Kauffman $2,274,945
Sharon Shacham $2,089,383
Christopher Primiano $1,522,593

Executive changes

Person Change Filed
Christy J. Oliger Appointed 2026-05-28
Barry E. Greene Appointed 2026-05-28
Mansoor Raza Mirza, M.D.
“Dr. Mirza’s resignation is due to competing professional demands and not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
Resigned 2025-09-11
Zhen Su, M.D., M.B.A. Appointed 2025-05-29
Garen G. Bohlin Appointed 2025-05-29
Lori Macomber Appointed 2025-01-02
Kristin Abate Appointed 2024-11-20
Michael Mason Resigned 2024-08-29
Chen Schor Appointed 2024-05-31
Richard Paulson Appointed 2024-05-31
Deepika R. Pakianathan Appointed 2024-05-31
Peter K Honig, M.D., MPH
“Dr. Honig’s resignation is due to competing professional demands and not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
Resigned 2023-12-08
Zhen Su, M.D., M.B.A Appointed 2023-09-01
Christy J. Oliger Appointed 2023-05-25
Mansoor Raza Mirza M.D. Appointed 2023-05-25
Barry E. Greene Appointed 2023-05-25
Stuart Poulton Appointed 2022-07-28
Ran Frenkel Resigned 2022-07-28
Sharon Shacham, Ph.D., M.B.A. Resigned 2022-03-29
Michael G. Kauffman, M.D. Ph.D. Resigned 2022-03-29
Michael G. Kauffman, M.D., Ph.D. Resigned 2022-03-28
Peter K Honig, M.D., MPH Appointed 2021-12-06
Mikael Dolsten Resigned 2021-12-06

Leadership

Key facts CIK 1503802 CUSIP 48576U205 13F (30d) 102 filings 86 filers Visit website Investor relations